Potential Antiangiogenic Treatment Eligibility of Patients with Squamous Non-Small-Cell Lung Cancer: EPISQUAMAB Study (GFPC 2015-01).
Saved in:
| Title: | Potential Antiangiogenic Treatment Eligibility of Patients with Squamous Non-Small-Cell Lung Cancer: EPISQUAMAB Study (GFPC 2015-01). |
|---|---|
| Authors: | Vergnenègre A; Centre Hospitalier Universitaire (CHU) Dupuytren, Limoges, France., Basse V; CHU Morvan, Brest, France., Le Garff G; CH Yves-Le-Foll, Saint-Brieuc, France., Bylicki O; Hôpital d'Instruction des Armées Percy, Clamart, France., Dubos-Arvis C; Centre François-Baclesse, Caen, France., Comet B; Centre Catalan d'Oncologie, Perpignan, France., Marcq M; CH Départemental Vendée, Les Oudairies, La Roche-Sur-Yon, France., Le Treut J; CH du Pays d'Aix, Aix-En-Provence, France., Auliac JB; Hôpital Quesnay, Mantes-La-Jolie, France., Madroszyk A; Institut Paoli-Calmettes, Marseille, France., Fraboulet G; CH René-Dubos, Cergy-Pontoise, France., Crequit J; CH Laennec, Creil, France., Thomas P; CH Intercommunal (CHI) Des Alpes-Du-Sud, Gap, France., Paleiron N; Hôpital d'Instruction Des Armées Sainte-Anne, Toulon, France., Monnet I; CHI Créteil, Créteil, France. |
| Corporate Authors: | French Lung Cancer Group |
| Source: | Cancer management and research [Cancer Manag Res] 2019 Dec 27; Vol. 11, pp. 10821-10826. Date of Electronic Publication: 2019 Dec 27 (Print Publication: 2019). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101512700 Publication Model: eCollection Cited Medium: Print ISSN: 1179-1322 (Print) Linking ISSN: 11791322 NLM ISO Abbreviation: Cancer Manag Res Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31920391 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Potential Antiangiogenic Treatment Eligibility of Patients with Squamous Non-Small-Cell Lung Cancer: EPISQUAMAB Study (GFPC 2015-01). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Vergnenègre+A%22">Vergnenègre A</searchLink>; Centre Hospitalier Universitaire (CHU) Dupuytren, Limoges, France.<br /><searchLink fieldCode="AU" term="%22Basse+V%22">Basse V</searchLink>; CHU Morvan, Brest, France.<br /><searchLink fieldCode="AU" term="%22Le+Garff+G%22">Le Garff G</searchLink>; CH Yves-Le-Foll, Saint-Brieuc, France.<br /><searchLink fieldCode="AU" term="%22Bylicki+O%22">Bylicki O</searchLink>; Hôpital d'Instruction des Armées Percy, Clamart, France.<br /><searchLink fieldCode="AU" term="%22Dubos-Arvis+C%22">Dubos-Arvis C</searchLink>; Centre François-Baclesse, Caen, France.<br /><searchLink fieldCode="AU" term="%22Comet+B%22">Comet B</searchLink>; Centre Catalan d'Oncologie, Perpignan, France.<br /><searchLink fieldCode="AU" term="%22Marcq+M%22">Marcq M</searchLink>; CH Départemental Vendée, Les Oudairies, La Roche-Sur-Yon, France.<br /><searchLink fieldCode="AU" term="%22Le+Treut+J%22">Le Treut J</searchLink>; CH du Pays d'Aix, Aix-En-Provence, France.<br /><searchLink fieldCode="AU" term="%22Auliac+JB%22">Auliac JB</searchLink>; Hôpital Quesnay, Mantes-La-Jolie, France.<br /><searchLink fieldCode="AU" term="%22Madroszyk+A%22">Madroszyk A</searchLink>; Institut Paoli-Calmettes, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Fraboulet+G%22">Fraboulet G</searchLink>; CH René-Dubos, Cergy-Pontoise, France.<br /><searchLink fieldCode="AU" term="%22Crequit+J%22">Crequit J</searchLink>; CH Laennec, Creil, France.<br /><searchLink fieldCode="AU" term="%22Thomas+P%22">Thomas P</searchLink>; CH Intercommunal (CHI) Des Alpes-Du-Sud, Gap, France.<br /><searchLink fieldCode="AU" term="%22Paleiron+N%22">Paleiron N</searchLink>; Hôpital d'Instruction Des Armées Sainte-Anne, Toulon, France.<br /><searchLink fieldCode="AU" term="%22Monnet+I%22">Monnet I</searchLink>; CHI Créteil, Créteil, France. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22French+Lung+Cancer+Group%22">French Lung Cancer Group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101512700%22">Cancer management and research</searchLink> [Cancer Manag Res] 2019 Dec 27; Vol. 11, pp. 10821-10826. <i>Date of Electronic Publication: </i>2019 Dec 27 (<i>Print Publication: </i>2019). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Dove+Medical+Press%22">Dove Medical Press </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101512700 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1179-1322 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211791322%22">11791322 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Manag Res <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31920391 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.2147/CMAR.S219984 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 10821 Titles: – TitleFull: Potential Antiangiogenic Treatment Eligibility of Patients with Squamous Non-Small-Cell Lung Cancer: EPISQUAMAB Study (GFPC 2015-01). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Vergnenègre A – PersonEntity: Name: NameFull: Basse V – PersonEntity: Name: NameFull: Le Garff G – PersonEntity: Name: NameFull: Bylicki O – PersonEntity: Name: NameFull: Dubos-Arvis C – PersonEntity: Name: NameFull: Comet B – PersonEntity: Name: NameFull: Marcq M – PersonEntity: Name: NameFull: Le Treut J – PersonEntity: Name: NameFull: Auliac JB – PersonEntity: Name: NameFull: Madroszyk A – PersonEntity: Name: NameFull: Fraboulet G – PersonEntity: Name: NameFull: Crequit J – PersonEntity: Name: NameFull: Thomas P – PersonEntity: Name: NameFull: Paleiron N – PersonEntity: Name: NameFull: Monnet I IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 12 Text: 2019 Dec 27 Type: published Y: 2019 Identifiers: – Type: issn-print Value: 1179-1322 Numbering: – Type: volume Value: 11 Titles: – TitleFull: Cancer management and research Type: main |
| ResultId | 1 |